HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Min Hong Selected Research

yu ping feng san

11/2019Huangqi-Fangfeng protects against allergic airway remodeling through inhibiting epithelial-mesenchymal transition process in mice via regulating epithelial derived TGF-β1.
7/2019Chinese medicine Yu-Ping-Feng-San attenuates allergic inflammation by regulating epithelial derived pro-allergic cytokines.
2/2019Yu-Ping-Feng-San ameliorates recurrent allergic inflammation of atopic dermatitis by repairing tight junction defects of the epithelial barrier.
1/2019A Chinese Prescription Yu-Ping-Feng-San Administered in Remission Restores Bronchial Epithelial Barrier to Inhibit House Dust Mite-Induced Asthma Recurrence.
1/2014Screening active components from Yu-ping-feng-san for regulating initiative key factors in allergic sensitization.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Min Hong Research Topics

Disease

16Neoplasms (Cancer)
06/2022 - 03/2009
14Inflammation (Inflammations)
02/2021 - 04/2010
8Hypersensitivity (Allergy)
02/2019 - 07/2002
7Atopic Dermatitis (Atopic Eczema)
02/2021 - 01/2017
5Asthma (Bronchial Asthma)
01/2021 - 04/2013
5B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
04/2016 - 10/2009
3Infections
01/2021 - 01/2009
3Allergic Contact Dermatitis
01/2018 - 04/2010
2Poisoning
02/2022 - 01/2021
2Hypoxia (Hypoxemia)
12/2021 - 04/2018
2Edema (Dropsy)
12/2021 - 10/2019
2Squamous Cell Carcinoma of Head and Neck
01/2021 - 01/2020
2Neoplasm Metastasis (Metastasis)
01/2021 - 04/2015
2Human Influenza (Influenza)
01/2021 - 05/2020
2Liver Diseases (Liver Disease)
12/2020 - 02/2012
2Hepatocellular Carcinoma (Hepatoma)
12/2020 - 12/2013
2Contact Dermatitis (Eczema, Contact)
10/2018 - 01/2014
2Type 2 Diabetes Mellitus (MODY)
04/2017 - 01/2016
2Breast Neoplasms (Breast Cancer)
06/2016 - 10/2015
2Colonic Neoplasms (Colon Cancer)
11/2014 - 05/2014
2Hematologic Neoplasms (Hematological Malignancy)
12/2013 - 12/2008
2Endometriosis
03/2004 - 01/2003
1Hemorrhage
12/2022
1Acute Kidney Injury (Acute Renal Failure)
12/2022
1Liver Cirrhosis (Hepatic Cirrhosis)
12/2022
1Lung Diseases (Lung Disease)
09/2022
1Atrophy
09/2022
1Skin Neoplasms (Skin Cancer)
09/2022
1Shock
03/2022
1Respiratory Insufficiency (Respiratory Failure)
02/2022
1Pharyngitis (Sore Throat)
12/2021
1Acute Lung Injury
12/2021
1Coronary Artery Disease (Coronary Atherosclerosis)
10/2021
1Wounds and Injuries (Trauma)
12/2020
1Fibrosis (Cirrhosis)
12/2020
1Virus Diseases (Viral Diseases)
11/2020

Drug/Important Bio-Agent (IBA)

11Proteins (Proteins, Gene)FDA Link
01/2021 - 07/2002
7CytokinesIBA
07/2019 - 03/2004
6MicroRNAs (MicroRNA)IBA
10/2018 - 07/2012
5Messenger RNA (mRNA)IBA
01/2021 - 04/2018
5yu ping feng sanIBA
11/2019 - 01/2014
5Fluorescein-5-isothiocyanate (FITC)IBA
02/2019 - 06/2016
4formononetinIBA
02/2021 - 01/2014
4EnzymesIBA
12/2020 - 01/2003
4Immunoglobulin E (IgE)IBA
05/2020 - 04/2013
3Huang QiIBA
01/2020 - 01/2018
37,3'-dihydroxy-4'-methoxyisoflavoneIBA
01/2020 - 01/2017
3Thymic Stromal LymphopoietinIBA
10/2018 - 01/2014
2PesticidesIBA
02/2022 - 01/2021
2CalciumIBA
10/2021 - 01/2016
2Flavin Mononucleotide (FMN)IBA
02/2021 - 01/2020
2Estrogen ReceptorsIBA
02/2021 - 01/2020
2GTP-Binding Proteins (G-Protein)IBA
02/2021 - 01/2020
2Transcription Factors (Transcription Factor)IBA
01/2021 - 04/2016
2Interleukin-33IBA
01/2021 - 12/2016
2Poly I-CIBA
01/2020 - 10/2018
2AllergensIBA
11/2019 - 11/2019
2Telomerase (Telomerase Reverse Transcriptase)IBA
05/2019 - 12/2016
2Interleukin-13IBA
02/2019 - 01/2019
2isothiocyanic acidIBA
02/2019 - 10/2018
2Fluorescein (Funduscein)FDA LinkGeneric
02/2019 - 10/2018
2Interleukin-5 (Interleukin 5)IBA
02/2019 - 01/2019
2Anti-Allergic Agents (Antiallergic Agents)IBA
02/2019 - 01/2018
2cimifuginIBA
02/2019 - 11/2017
2InterleukinsIBA
10/2018 - 12/2016
2Biomarkers (Surrogate Marker)IBA
04/2017 - 03/2015
2Peptides (Polypeptides)IBA
06/2016 - 10/2015
2DNA (Deoxyribonucleic Acid)IBA
01/2016 - 02/2008
1CreatinineIBA
12/2022
1Cystatin CIBA
12/2022
1RadonIBA
09/2022
1Phospholipid Hydroperoxide Glutathione PeroxidaseIBA
06/2022
1Lipid PeroxidesIBA
06/2022
1Glutathione (Reduced Glutathione)IBA
06/2022
1Reactive Oxygen Species (Oxygen Radicals)IBA
06/2022
1CarrageenanIBA
12/2021
1Xylenes (Xylene)IBA
12/2021
1NF-kappa B (NF-kB)IBA
12/2021
1NLR ProteinsIBA
12/2021
1Acetic Acid (Vinegar)FDA LinkGeneric
12/2021
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
12/2021
1OrganophosphatesIBA
01/2021
1CarbamatesIBA
01/2021
1BuffersIBA
01/2021
1AcidsIBA
01/2021
1InflammasomesIBA
01/2021
1ErbB Receptors (EGF Receptor)IBA
01/2021
1AntigensIBA
01/2021
1Erlotinib Hydrochloride (CP 358,774)FDA Link
01/2021
1E2F Transcription FactorsIBA
01/2021
1Methionine (L-Methionine)FDA Link
12/2020
1clonidine-displacing substance (ClDS)IBA
12/2020
1Methionine AdenosyltransferaseIBA
12/2020
1QuinolinesIBA
11/2020
1RNA (Ribonucleic Acid)IBA
11/2020
1Omalizumab (Xolair)FDA Link
05/2020
1Biological ProductsIBA
01/2020

Therapy/Procedure

7Therapeutics
06/2022 - 10/2015
2Aftercare (After-Treatment)
10/2019 - 05/2019
1Transcutaneous Electric Nerve Stimulation (TENS)
03/2022